Investigation Report on China's Shingles Vaccine Market 2022-2031

SKU ID : CRI- 21377470

Publishing Date : 25-Jul-2022

No. of pages : 40


  • The trade name of shingles vaccine (recombinant zoster vaccine) is SHINGRIX, which was developed by GlaxoSmithKline. Its product was firstly approved in China in 2020. Shingles vaccine is suitable for adults aged 50 years and over to protect against shingles (herpes zoster). The recombinant zoster vaccine has been listed in the Chinese market. By July 2022, GlaxoSmithKline Biologicals is the only manufacturer in the Chinese Shingles Vaccine market.
    According to researcher, since Shingles Vaccine entered the Chinese market in 2020, its annual sales value reached CNY19 million(US$2.85 million), and its annual sales volume reached nearly 12,000 doses. Therefore, the development prospects are quite good.
    According toresearcheranalysis, from 2022 to 2031, as Shingles Vaccine market expands, its sales will continue to grow. Compared with Merck’s Zostavax, SHINGRIX has better preventive effects and faster replacement velocity. Therefore, as the market share of Shingles Vaccine will gradually increase, and sales and sales volume will also increase.

    Topics Covered:
    The impact of COVID-19 on China's Shingles Vaccine market
    Sales volume and value of China's Shingles Vaccine 2020-2021
    Sales volume and value of Shingles Vaccine by regions in China 2020-2021
    Competitive landscape of China's Shingles Vaccine market
    Prices of Shingles Vaccine in China
    Prices of Shingles Vaccine in China by regions in China
    Analysis on factors affecting the development of China's Shingles Vaccine market
    Prospect of China's Shingles Vaccine market from 2022 to 2031

    Frequently Asked Questions

    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports